Keywords: EMA, Europe, Public consultation, Heparin, LMWHs, Draft guidelines

EMA consults on draft guideline for biosimilars containing low-molecular-weight heparins

Article | 03 February 2013

The European Medicines Agency has launched a six-month public consultation on the revised guideline on non-clinical and clinical development of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in